Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma

Oral Oncology

Volumn 48, Issue 5, 2012, Pages 424-428

  Cheng, Shih Jung ^a,b,c   Lee, Jang Jaer ^b,c   Cheng, Shih Lung ^d   Chen, Hsin Ming ^a,b,c   Chang, Hao Hueng ^b,c   Wang, Yi Ping ^a,b,c   Kok, Sang Heng ^b,c   Kuo, Mark Yen Ping ^a,b,c   Chiang, Chun Pin ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cancer progression; Cancer recurrence; Oral cancer; Prognosis; Serum placenta growth factor

Indexed keywords

PLACENTAL GROWTH FACTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECURRENCE FREE SURVIVAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PREGNANCY PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862796679     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.12.007     Document Type: Article

References (26)

1. Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006;6:1111-8. (Pubitemid 44203388)
2. Cancer registry annual report in Taiwan area, 2010. Department of Health, The Executive Yuan, Taiwan. 2011.
3. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001;345:1890-900. (Pubitemid 33716564)
4. Fischer C, Mazzone M, Jonckx B, Carmeliet P. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 2008;8: 942-56.
5. Marcellini M, De Luca N, Riccioni T, Ciucci A, Orecchia A, Lacal PM, et al. Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol 2006;169:643-54. (Pubitemid 44156320)
6. Lacal PM, Failla CM, Pagani E, Odorisio T, Schietroma C, Falcinelli S, et al. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol 2000;115:1000-7. (Pubitemid 32037443)
7. Ikai T, Miwa H, Shikami M, Hiramatsu A, Tajima E, Yamamoto H, et al. Placenta growth factor stimulates the growth of Philadelphia chromosome positive acute lymphoblastic leukemia cells by both autocrine and paracrine pathways. Eur J Haematol 2005;75:273-9. (Pubitemid 41297602)
8. Parr C, Watkins G, Boulton M, Cai J, Jiang WG. Placenta growth factor is overexpressed and has prognostic value in human breast cancer. Eur J Cancer 2005;41:2819-27. (Pubitemid 41713119)
9. Chen CN, Hsieh FJ, Cheng YM, et al. The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett 2004;213:73-82.
10. Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG. Expression of placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol 2005;3:68-79.
11. Wei SC, Tsao PN, Yu SC, Shun CT, Tsai-Wu JJ, Wu CH, et al. Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut 2005;54:666-72. (Pubitemid 40559252)
12. Ho MC, Chen CN, Lee H, Hsieh FJ, Shun CT, Chang CL, et al. Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma. Cancer Lett 2007;250:237-49. (Pubitemid 46529444)
13. Cheng SJ, Lee JJ, Kok SH, Chou CH, Chang HH, Chiang ML, et al. Expression of placenta growth factor: an independent factor for prediction of progression and prognosis of oral cancer. Head Neck 2010;32:1363-9.
14. Matsumoto K, Suzuki K, Koike H, Okamura K, Tsuchiya K, Yamanaka H, et al. Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels. Anticancer Res 2003;23:4953-8. (Pubitemid 38182110)
15. Sabbaghian MS, Rothberger G, Alongi AP, Gagner JP, Goldberg JD, Shamamian P, et al. Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma. Anticancer Res 2010;30:2911-7.
16. Chang YT, Chang MC, Wei SC, Tien YW, Hsu C, Wong JM, et al. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer. Pancreas 2008;37:145-50.
17. Wei SC, Liang JT, Tsao PN, Hsieh FJ, Yu SC, Wong JM. Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer. Dis Colon Rectum 2009;52:1630-6.
18. Rahbari M, Reissfelder C, Muehlbayer M, Weidemann K, Kahlert C, Buechler MW, et al. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastasis. Ann Surg Oncol 2011;18:2182-91.
19. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. 6th ed. New York: Wiley; 2002. p. 19-35.
20. Shantha Kumara HMC, Cabot JC, Yan X, Herath SAC, Luchtefeld M, Kalady MF, et al. Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection. Surg Endosc 2011;25: 2153-8.
21. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
22. Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK. Mechanisms of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 2003;102:1515-24. (Pubitemid 36988064)
23. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998;179:1539-43.
24. Mehendale R, Hibbard J, Fazleabas A, Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am J Obstet Gynecol 2007;197:363 e1-5.
25. Jeyabalan A, Powers RW, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, et al. Effect of smoking on circulating angiogenic factors in high risk pregnancies. PLoS One 2010;5:e13270.
26. Cheng SL, Wang HC, Yu CJ, Yang PC. Increased expression of placenta growth factor in COPD. Thorax 2008;63:500-6.